Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy

Cancer

Volumn 115, Issue 12, 2009, Pages 2710-2720

  He, Jian ^a   Zeng, Zhao Chong ^a   Tang, Zhao You ^a   Fan, Jia ^a   Zhou, Jian ^a   Zeng, Meng Su ^a   Wang, Jian Hua ^a   Sun, Jing ^a   Chen, Bing ^a   Yang, Ping ^a   Pan, Bai Sheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Bone metastases; External beam radiotherapy; Hepatocellular carcinoma; Prognostic

Indexed keywords

ALPHA FETOPROTEIN; GAMMA GLUTAMYLTRANSFERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE LESION; BONE METASTASIS; BONE PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SOFT TISSUE; SPINE; TUMOR VOLUME;

BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PAIN; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649235652     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24300     Document Type: Article

References (22)

1. Ratanatharathorn V, Powers WE, Moss WT, et al. Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys. 1999;44:1-18. (Pubitemid 29186183)
2. Ho CL, Chen S, Yeung DWC, et al. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med. 2007;48:902-909. (Pubitemid 46909918)
3. Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol. 2005;20:1781-1787. (Pubitemid 43961087)
4. Fukutomi M, Yokota M, Chuman H, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13:1083-1088. (Pubitemid 32905203)
5. Kachnic L, Berk L. Palliative single-fraction radiation therapy: how much more evidence is needed? J Natl Cancer Inst. 2005;97:786-788.
6. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:798-804. (Pubitemid 40909122)
7. Chinese Liver Cancer Association. The diagnostic criteria and stages of primary hepatoma in the 4th national conference of liver cancer: problems and discussion. Chinese J Gen Surg. 2000;15:238-239.
8. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52(suppl 2):1-8. (Pubitemid 36520856)
9. Frazer C. Imaging of hepatocellular carcinoma. J Gastroenterol Hepatol. 1999;14:750-756. (Pubitemid 29426407)
10. Loyer EM, Chin H, DuBrow RA, et al. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT - a comparative study. Radiology. 1999;212:866-875. (Pubitemid 29410995)
11. Blacher A, Federle MP, Ferris JV, et al. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002;223:532-539. (Pubitemid 34454339)
12. Ventafridda V, Saita L, Ripamonti C, et al. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React. 1985;7:93-96. (Pubitemid 15109364)
13. ven der Linden YM, Lok JJ, Steenland E, et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch bone metastasis study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004;59:528-537. (Pubitemid 38622611)
14. Chow E, Wu J, Hoskin P, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol. 2002;64:275-280. (Pubitemid 35254020)
15. Capocaccia R, Sant M, Berrino F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol. 2007;102:1661-1670.
16. Yang BH, Xia JL, Huang LW, et al. Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int. 2004;3:194-198. (Pubitemid 38660148)
17. Toyoda H, Kumada T, Kiriyama S, et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Cancer. 2004;100:2415-2421.
18. Kaizu T, Karasawa K, Tanaka Y, et al. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol. 1998;93:2167-2171. (Pubitemid 29076869)
19. Seong J, Koom WS, Park HC. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int. 2005;25:261-265. (Pubitemid 40500558)
20. Yeo W, Mo FKF, Koh J, et al. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol. 2006;17:1083-1089. (Pubitemid 43985243)
21. Rades D, Fehlauer F, Schulte R, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol. 2006;24:3388-3393. (Pubitemid 46638894)
22. Goblirsch MJ, Zwolak PP, Clohisy DR. Biology of bone cancer pain. Clin Cancer Res. 2006;12:6231s-6235s. (Pubitemid 44703795)